Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Christopher Freet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
DeltaFosB and Reward Comparison in Mice
Freet, C. (CoPI)
NATIONAL INSTITUTE ON DRUG ABUSE
8/1/08 → 7/31/09
Project: Research project
-
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague–Dawley rats
Evans, B., Acharya, N., Brandl, C. G., Shealy, E. G., Nyland, J. E., Freet, C. S., Bunce, S. C. & Grigson, P. S., Oct 2026, In: Behavioural Pharmacology. 37, 5, p. 249-265 17 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Glucagon-Like Peptide-1 Receptor Agonists as a Candidate Treatment for Opioid Use Disorder: From Rats to Humans
Grigson, P. S., Bunce, S. C., Brick, T. R., Freet, C. S., Nyland, J. E., Kawasaki, S. S., Brandl, C. G., Shealy, E. & Huddleston, K., Oct 15 2026, In: Biological Psychiatry. 100, 8, p. 823-830 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential Treatment
Petrie, D. J., Knapp, K. S., Freet, C. S., Deneke, E., Stankoski, D., Brick, T. R., Cleveland, H. H. & Bunce, S. C., 2025, In: Substance Use and Misuse. 60, 7, p. 978-988 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol
Freet, C. S., Shuler, K., Kawasaki, S., Weintraub, E., Greenblatt, A., Kladney, M., Nunes, E., Foster, K. L., Kong, L., Raja-Khan, N., Cleveland, H. H., Grigson, P. S., Bunce, S. C., Brick, T. R. & Nyland, J. E., Dec 2025, In: Addiction Science and Clinical Practice. 20, 1, 89.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder
Freet, C. S., Evans, B., Brick, T. R., Deneke, E., Wasserman, E. J., Ballard, S. M., Stankoski, D. M., Kong, L., Raja-Khan, N., Nyland, J. E., Arnold, A. C., Krishnamurthy, V. B., Fernandez-Mendoza, J., Cleveland, H. H., Scioli, A. D., Molchanow, A., Messner, A. E., Ayaz, H., Grigson, P. S. & Bunce, S. C., Dec 2024, In: Addiction Science and Clinical Practice. 19, 1, 56.Research output: Contribution to journal › Article › peer-review
Open Access18 Link opens in a new tab Scopus citations